Under construction – not a live service
Sign in

2023-503362-24-01CompletedPhase 2

68Ga satoreotide trizoxetan PET/CT in patients with high grade neuroendocrine lung cancer

Source: EU CTIS (euclinicaltrials.eu) · Last updated 10 May 2023

Next steps

Brief summary (registry, in English)

The aim of this study is to investigate the uptake of the new positron emission tomography (PET-)tracer 68Ga-satoreotide trizoxetan in patients with high-grade neuroendocrine lung cancer.

Status (registry)
Completed
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
20 (actual)
First submitted
24 Apr 2023
Start date
9 Aug 2023
Lead sponsor
Rigshospitalet
Diseases
Lung cancer
EU CT number
2023-503362-24-01

What you commit to

  • Study type: Interventional · Phase 2
  • Participants enrolled: 20
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous radiotherapy to target lesions in the lungs
  • Previous or current treatment with somatostatin analogues
  • Current complete response to therapy

Other illness

  • Carcinoid syndrome
  • Other active malignancy, except for non-melanoma skin cancer
  • Allergy to somatostatin analogues

Other

  • Unknown primary tumor
  • Pregnancy or lactation
  • Communication difficulties, including inability to understand the oral and/or written study material

Who the study is looking for

  • Pathologically verified SCLC or LCNEC
  • Age ≥ 18 years
  • Informed oral and written consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
RigshospitaletCopenhagen OeDenmarkCompleted

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.